Sai Zhang
Qingdao, 266071, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Discovery of an Androgen Receptor Degrader Featuring a Pyridazinyl Glutarimide CRBN-Binding Motif for Transdermal Treatment of Androgenetic Alopecia.
Journal: Journal of medicinal chemistry
Published: May 29, 2026
Preserving the UFMylation-cilium axis mitigates blue light-induced retinal degeneration.
Journal: Journal of molecular cell biology
Published: March 12, 2026
ZJK-807: A Selective PROTAC Degrader of KRASG12D Overcoming Resistance in Pancreatic Cancer.
Journal: Journal of medicinal chemistry
Published: September 25, 2025
Discovery of LYA914, An Orally Bioavailable PROTAC Degrader Targeting the DNA Binding Domain of the Androgen Receptor for the Treatment of CRPC.
Journal: Journal of medicinal chemistry
Published: July 28, 2025
Rational Design of Dual Degraders by Incorporating Molecular Glue Structural Features into PROTAC Degraders.
Journal: Journal of medicinal chemistry
Published: May 09, 2025
PSMA-Guided PROTAC Degraders for Tumor-Specific Protein Degradation in Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: May 02, 2025
Restoration of N-glycosylation via leucine-activated leucyl-tRNA synthetase 1 overcomes chemoresistance in intrahepatic cholangiocarcinoma.
Journal: Journal of hepatology
Published: December 18, 2024
Ginkgolic acid inhibits CD8+ T cell activation and induces ferroptosis by lactate dehydrogenase A to exert immunosuppressive effect.
Journal: Journal of pharmaceutical analysis
Published: October 13, 2024
KIF11 UFMylation Maintains Photoreceptor Cilium Integrity and Retinal Homeostasis.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 16, 2024
Discovery of BWA-522, a First-in-Class and Orally Bioavailable PROTAC Degrader of the Androgen Receptor Targeting N-Terminal Domain for the Treatment of Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: August 09, 2023
Ginkgolic acid inhibits the expression of SAE1 and induces ferroptosis to exert an anti-hepatic fibrosis effect.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 28, 2023
Last Updated: 09/26/2026